Tag Archives: non-hodgkin lymphoma

November, 2018

September, 2018

July, 2018

December, 2017

August, 2017

June, 2017

May, 2017

  • 30 May

    FDA Grants Priority Review to Kite Pharma’s Non-Hodgkin Lymphoma Drug

    SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for axicabtagene ciloleucel. The submission follows positive data demonstrated with a single infusion of axicabtagene ciloleucel in the …

April, 2017

February, 2017

December, 2016